Among reasons for the rejection, the agency cited a lack of US patient representation in the STARGLO trial assessing ...

The Baloch Liberation Army (BLA) asserted that its members killed at least seven Pakistani soldiers during a military ...

The safety issue has been especially concerning in Pakistan's Balochistan province where China has funded and built the ...

The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus ...

In the aftermath of attacks on Chinese nationals and projects in Pakistan, China expressed strong dissatisfaction to visiting ...

Omeros (OMER) has entered into a securities purchase agreement with Polar Asset Management Partners to sell about $22 million of its common stock in a registered direct offering.

Investing.com -- Atara Biotherapeutics Inc (NASDAQ: ATRA) stock surged 7% after the U.S. Food and Drug Administration (FDA) accepted the filing of its Biologics License Application (BLA) for ...

Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

Atara Biotherapeutics Inc (NASDAQ:ATRA) saw its stock jump 7% following the U.S. Food and Drug Administration’s acceptance of ...

FDA issued Complete Response Letter Capricor plans to resubmit its BLA to include data from the ongoing Phase 3 HOPE-3 trial in Q3 2025 to continue pursuing the indication for the treatment of ...

The Baloch Liberation Army has claimed responsibility for a bomb blast in Quetta that killed Major Anwar Kakar, a senior ...

The FDA's request stems from observations made during recent inspections of Ultragenyx's manufacturing facilities.